These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8807059)
1. NorA plasmid resistance to fluoroquinolones: role of copy number and norA frameshift mutations. Sun L; Sreedharan S; Plummer K; Fisher LM Antimicrob Agents Chemother; 1996 Jul; 40(7):1665-9. PubMed ID: 8807059 [TBL] [Abstract][Full Text] [Related]
2. Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration. Kaatz GW; Seo SM; Foster TJ Antimicrob Agents Chemother; 1999 Sep; 43(9):2222-4. PubMed ID: 10471568 [TBL] [Abstract][Full Text] [Related]
3. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Kaatz GW; Seo SM Antimicrob Agents Chemother; 1995 Dec; 39(12):2650-5. PubMed ID: 8592996 [TBL] [Abstract][Full Text] [Related]
4. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Kaatz GW; Seo SM; Ruble CA Antimicrob Agents Chemother; 1993 May; 37(5):1086-94. PubMed ID: 8517696 [TBL] [Abstract][Full Text] [Related]
5. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Ng EY; Trucksis M; Hooper DC Antimicrob Agents Chemother; 1994 Jun; 38(6):1345-55. PubMed ID: 8092836 [TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Neyfakh AA; Borsch CM; Kaatz GW Antimicrob Agents Chemother; 1993 Jan; 37(1):128-9. PubMed ID: 8431010 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the nucleotide sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus. Noguchi N; Okada H; Narui K; Sasatsu M Microb Drug Resist; 2004; 10(3):197-203. PubMed ID: 15383162 [TBL] [Abstract][Full Text] [Related]
8. Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA. Muñoz-Bellido JL; Alonzo Manzanares M; Martínez Andrés JA; Guttiérrez Zufiaurre MN; Ortiz G; Segovia Hernández M; García-Rodríguez JA Antimicrob Agents Chemother; 1999 Feb; 43(2):354-6. PubMed ID: 9925531 [TBL] [Abstract][Full Text] [Related]
9. Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter. Kaatz GW; Thyagarajan RV; Seo SM Antimicrob Agents Chemother; 2005 Jan; 49(1):161-9. PubMed ID: 15616291 [TBL] [Abstract][Full Text] [Related]
10. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. Ubukata K; Itoh-Yamashita N; Konno M Antimicrob Agents Chemother; 1989 Sep; 33(9):1535-9. PubMed ID: 2817852 [TBL] [Abstract][Full Text] [Related]
11. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. Yoshida H; Bogaki M; Nakamura S; Ubukata K; Konno M J Bacteriol; 1990 Dec; 172(12):6942-9. PubMed ID: 2174864 [TBL] [Abstract][Full Text] [Related]
12. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Takenouchi T; Tabata F; Iwata Y; Hanzawa H; Sugawara M; Ohya S Antimicrob Agents Chemother; 1996 Aug; 40(8):1835-42. PubMed ID: 8843290 [TBL] [Abstract][Full Text] [Related]
13. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176 [TBL] [Abstract][Full Text] [Related]
14. [Characterization of the Staphylococcus aureus norA gene, which confers resistance to hydrophilic quinolones]. Yoshida H Nihon Rinsho; 1992 May; 50(5):1042-8. PubMed ID: 1324331 [TBL] [Abstract][Full Text] [Related]
15. Construction of a gyrA plasmid for genetic characterization of fluoroquinolone-resistant Staphylococcus aureus. Tankovic J; Duval J; Courvalin P FEMS Immunol Med Microbiol; 1994 Jun; 9(1):35-9. PubMed ID: 7920462 [TBL] [Abstract][Full Text] [Related]
16. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model. Aeschlimann JR; Kaatz GW; Rybak MJ J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401 [TBL] [Abstract][Full Text] [Related]
17. NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes. Yu JL; Grinius L; Hooper DC J Bacteriol; 2002 Mar; 184(5):1370-7. PubMed ID: 11844766 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus. Ince D; Hooper DC Antimicrob Agents Chemother; 2001 Oct; 45(10):2755-64. PubMed ID: 11557465 [TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus. Fukuda H; Hori S; Hiramatsu K Antimicrob Agents Chemother; 1998 Aug; 42(8):1917-22. PubMed ID: 9687384 [TBL] [Abstract][Full Text] [Related]
20. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Markham PN; Westhaus E; Klyachko K; Johnson ME; Neyfakh AA Antimicrob Agents Chemother; 1999 Oct; 43(10):2404-8. PubMed ID: 10508015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]